MedPharm opens a new topical and transdermal formulation-development services facility in Guildford, United Kingdom.
MedPharm, a speciality pharmaceutical company providing topical and transdermal formulation development services, has opened a new £.5 million ($680 thousand) GMP facility in Guildford, United Kingdom.
The investment adds a microbiology laboratory, cleanroom suites, an ICH stability testing area, and quality-control and performance-testing laboratories to support Phase I and II clinical manufacture. The facility also allows for the manufacture of highly potent compounds up to OEB level 4 with a manufacturing batch scale of up to 50 kg and primary packaging, labeling, and randomization services.
